NCT06839586 is a Phase 1, PHASE2 clinical trial of CMTS4520 (dietary fiber and probiotics) in Diarrhoea, sponsored by The Second Hospital of Nanjing Medical University.

Who is sponsoring NCT06839586?

NCT06839586 is sponsored by The Second Hospital of Nanjing Medical University.

What drugs are being tested in NCT06839586?

Interventions in NCT06839586: CMTS4520 (dietary fiber and probiotics), Placebo.

Is NCT06839586 still recruiting?

NCT06839586 is currently active, enrolled. Last updated 18 November 2025.

Last reviewed 2025-11-18 · How we verify

NCT06839586

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CMTS4520 for Chronic Diarrhoea in Adults

Active, enrolled Phase 1, PHASE2 Last updated 18 November 2025

What this trial tests

Phase 1, PHASE2 trial testing CMTS4520 (dietary fiber and probiotics) in Diarrhoea in 100 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

20 February 2025

Primary endpoint
31 January 2030

1 July 2030

Quick facts

Lead sponsor	The Second Hospital of Nanjing Medical University
Phase	Phase 1, PHASE2
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	100
Start date	20 February 2025
Primary completion	31 January 2030
Estimated completion	1 July 2030
Sites	1 location across China

Drugs / interventions tested

CMTS4520 (dietary fiber and probiotics) — full drug profile →
Placebo

Conditions studied

Diarrhoea — all drugs for Diarrhoea →

Sponsor

The Second Hospital of Nanjing Medical University

Who can join

Adults 18 to 70, any sex, with Diarrhoea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized controlled trial to explore the efficacy and safety of CMTS4520 (Dietary Fiber Probiotics) for patients with chronic diarrhoea.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other The Second Hospital of Nanjing Medical University trials

Trials by the same sponsor.

NCT07331688 — CMTS0515-auWMT for Radiation Enteritis · Phase 1, PHASE2 · active not recruiting
NCT06836427 — CMTS0929 for Clostridioides Difficile Infection · EARLY_PHASE1 · not yet recruiting
NCT06839599 — CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Diarrhoea in Adults · Phase 1, PHASE2 · not yet recruiting
NCT06844708 — CMTS0929 for Inflammatory Bowel Disease · EARLY_PHASE1 · not yet recruiting
NCT06832176 — CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Constipation in Adults · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06839586 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Second Hospital of Nanjing Medical University
Last refreshed: 18 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06839586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing